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Abstract
Background: The repressor element-1 (RE1) silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) is a
master transcriptional regulator that binds to numerous genomic RE1 sites where it acts as a molecular scaffold for dynamic
recruitment of modulatory and epigenetic cofactors, including corepressor for element-1-silencing transcription factor
(CoREST). CoREST also acts as a hub for various cofactors that play important roles in epigenetic remodeling and
transcriptional regulation. While REST can recruit CoREST to its macromolecular complex, CoREST complexes also function at
genomic sites independently of REST. REST and CoREST perform a broad array of context-specific functions, which include
repression of neuronal differentiation genes in neural stem cells (NSCs) and other non-neuronal cells as well as promotion of
neurogenesis. Despite their involvement in multiple aspects of neuronal development, REST and CoREST are not believed to
have any direct modulatory roles in glial cell maturation.
Methodology/Principal Findings: We challenged this view by performing the first study of REST and CoREST in NSC-
mediated glial lineage specification and differentiation. Utilizing ChIP on chip (ChIP-chip) assays, we identified distinct but
overlapping developmental stage-specific profiles for REST and CoREST target genes during astrocyte (AS) and
oligodendrocyte (OL) lineage specification and OL lineage maturation and myelination, including many genes not
previously implicated in glial cell biology or linked to REST and CoREST regulation. Amongst these factors are those
implicated in macroglial (AS and OL) cell identity, maturation, and maintenance, such as members of key developmental
signaling pathways and combinatorial transcription factor codes.
Conclusions/Significance: Our results imply that REST and CoREST modulate not only neuronal but also glial lineage
elaboration. These factors may therefore mediate critical developmental processes including the coupling of neurogenesis
and gliogenesis and neuronal-glial interactions that underlie synaptic and neural network plasticity and homeostasis in
health and in specific neurological disease states.
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Introduction
The repressor element-1 silencing transcription factor/neuron-
restrictive silencer factor (REST/NRSF) is a master transcriptional
and post-transcriptional regulator [1] that modulates distinct sets
of protein-coding and non-coding genes in specific cell types, such
as embryonic stem cells (ESCs) and neural stem cells (NSCs) [2],
and has a broad array of context-specific functions including the
regulation of embryonic development [3], neurogenesis [4,5],
synaptic plasticity [4], neurosecretory mechanisms [6], and
extracellular matrix composition [7]. Aberrant REST expression
and function are implicated in diverse disorders including cancer
[8], neurodegeneration [9] and neurodevelopmental diseases [10].
REST was initially believed to repress expression of genomic
repressor element-1 (RE1) motif containing neuronal differentia-
tion genes in NSCs and in non-neuronal cells by recruiting
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its N- and C-terminal binding domains, including the corepressor
for element-1-silencing transcription factor (CoREST) to its C-
terminus [11,12,13], to form a modular macromolecular complex.
REST is now believed to have an increasing spectrum of
developmental stage- and cell type-specific functions, including
gene activation, repression, and long-term gene silencing, that are
modulated by factors such as the levels of REST protein
expression, the affinity of the REST complex for specific genomic
loci, and the presence of regulatory cofactors (e.g., modulatory
double-stranded ncRNAs and distinct isoforms of REST)
[11,14,15,16].
Like REST, CoREST also regulates neuronal gene expression
by acting as a scaffold for the recruitment of various epigenetic
factors that play roles in chromatin remodeling, including MeCP2,
HDAC1/2, LSD1, BHC80, and BRAF35 [17,18]. Distinct
CoREST complexes can bind to REST or function independently
in order to modulate target gene expression [4,19]. For example,
one study demonstrated that for a subset of neuronal genes,
designated class I, absence of the REST complex results in
maximal levels of gene expression, whereas for class II neuronal
genes, absence of the REST complex only results in submaximal
levels of gene expression due to repressive effects from a separate
CoREST complex bound to distinct sites on the promoters of
these genes [4].
Although various studies have identified genes that are targets for
REST in ESCs, NSCs, and other cell types [20,21,22,23,24], a
detailed understanding of the roles played by REST and CoREST in
governing developmental gene expression programs is still emerging.
In this study, we characterize developmental stage-specific profiles for
REST and CoRESTtarget genes in glial cells, including thousands of
genes not previously described as targets for REST regulation. These
include factors known to be involved in the acquisition and
maintenance of macroglial (astrocyte [AS] and oligodendrocyte
[OL]) cell identity and functions as well as those that have not been
previously associated with glial cell biology. These findings now
implicate REST and CoREST in a previously unrecognized role—
regulation of glial lineage elaboration, including AS and OL
specification and progressive stages of OL lineage maturation.
Our observations suggest that REST and CoREST are key
nodes in the epigenetic regulatory circuitry governing both
neuronal and glial gene expression and may also be responsible
for coordinating AS functions, such as controlling trophic neural
microenvironments and modulating synaptic plasticity, and OL
functions, such as mediating neuronal-glial interactions and axonal
myelination.
Results
We examined the molecular mechanisms underlying glial
lineage elaboration by assessing REST and CoREST protein
expression and profiling of REST and CoREST target genes using
ChIP-chip analysis in a developmental paradigm comprised of
both immature and mature glial cell types. We identified profiles
for REST and CoREST target genes that are unique to specific
cell types as well as those found in combinations throughout
critical developmental transitions associated with glial lineage
specification and progressive stages of OL lineage maturation. We
examined these transitions to better understand the specific ways
in which REST and CoREST modulate glial developmental states
and gene expression programs. Specifically, we studied the
following critical developmental transitions: specification of
astrocytes [neural stem cells R astrocytes (NSCs R ASs)],
specification of OL precursors [bipotent progenitor cells R OL
precursors (N/OPs R OLpres)], and progressive stages of OL
lineage maturation including myelination [OL precursors R OL
progenitors (OLpres R OL pros), OL progenitors R post-mitotic
OLs (OLpros R pmOLs), and post-mitotic OLs R mature,
myelin expressing OLs (pmOLs R myOLs)]. In addition, we
correlated REST and CoREST promoter occupancy with
corresponding gene expression profiles to interrogate their
potential regulatory roles in macroglial lineage elaboration.
REST and CoREST Expression and Subcellular Localization
We measured REST and CoREST expression and subcellular
localization throughout glial lineage elaboration by performing
immunofluorescence microscopy and Western blot analysis
(Figure 1). We found that both proteins are ubiquitously expressed
in the nucleus and cytoplasm of all cell types examined in our
developmental paradigm. Together, these observations suggest
that REST and CoREST are present in all glial cell types and
therefore have the potential to regulate gene expression profiles
during glial subtype specification and progressive stages of OL
lineage maturation.
Genome-Wide Promoter Occupancy Profiles for REST and
CoREST
While REST and CoREST expression and subcellular
localization remain relatively constant, we found that there is
significant variation in the number of promoter sites they occupy
in each of the different glial developmental cell types (Figure 2A).
We found a total of 3,178 REST and 4,060 CoREST target genes
across all glial cell types examined (Table S1). Amongst these
genes, we found that 1,535 are ‘‘exclusive’’ targets of REST; 2,417
are exclusive targets of CoREST; and 1,643 are targets of both
REST and CoREST (REST-CoREST). We designated these
genes as ‘‘unique’’ targets if they were bound solely within one of
the glial cell types examined. For ASs, we identified 287 unique
and exclusive REST target genes; 40 unique and exclusive
CoREST target genes; and 10 unique REST-CoREST target
genes. For OLpres, OLpros, pmOLs, and myOLs, we identified
127, 398, 465, and 502 unique and exclusive REST target genes;
and we found 767, 312, 346, and 305 unique and exclusive
CoREST target genes. For OLpres, OLpros, pmOLs, and myOLs
we further identified 60, 20, 43, and 131 unique REST-CoREST
target genes. Interestingly, these observations demonstrate a
progressive increase in the number of unique and exclusive REST
target genes during OL lineage maturation, suggesting that REST
may acquire more diverse roles as OLs undergo progressive
lineage maturation, cell cycle exit, and myelination. In contrast,
CoREST binds to a disproportionately large number of unique
and exclusive target genes in OLpres, implying that it may have a
preferential role in OL lineage specification. These striking
observations reveal that REST and CoREST have distinct profiles
of target genes in each glial subtype and suggest that they perform
largely non-overlapping developmental stage-specific regulatory
functions during glial lineage elaboration.
Further, we compared glial target genes with a previously
characterized set of RE1-containing genes (Figure 2B) [20,22]. We
observed that the percentages of RE1-containing REST, CoR-
EST, and REST-CoREST target genes range from 25.6% to
53.0% across OL developmental lineage species. Alternatively, for
the AS lineage, we found a more consistent percentage of RE1-
containing target genes at the lower end of this range, with REST,
CoREST, and REST-CoREST targets having 25.6%, 26.4%, and
28.7%, respectively. These results demonstrate that, in glial cells,
REST and CoREST primarily target genes that have not
previously been characterized as containing RE1 motifs. These
REST and CoREST in Glial Cells
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REST and CoREST DNA binding motifs may encode lineage-
specific functional information [25].
To begin to characterize the distinct roles of REST and
CoREST in modulating glial gene expression programs, we
compared profiles of REST and CoREST target genes from all
glial cell types to those from a corresponding study we performed
in neuronal subtypes (Figure 3). Unexpectedly, we found that
neuronal and glial REST and CoREST target gene profiles are
quite distinct. We observed that only 13% of REST target genes in
glia are also REST targets in neurons, 14% of CoREST target
genes in glia are also CoREST targets in neurons, and 5% of
REST-CoREST target genes in glia are also REST-CoREST
targets in neurons. These observations are highly statistically
significant with corresponding p-values,0.0001 (i.e., cumulative
probability calculated using hypergeometric testing) for the
number of overlapping glial and neuronal genes in each
comparison. These findings show that a relatively small number
of REST and CoREST target genes are common to both neuronal
and glial lineages and strongly suggest that REST and CoREST
regulate distinct sets of genes and developmental events during
neuronal and glial lineage elaboration.
REST and CoREST Target Gene Profiles during Seminal
Developmental Transitions in Glial Lineage Elaboration
In order to better understand the potential maturational and
maintenance functions of REST and CoREST, we identified
subsets of genes that were targeted throughout seminal develop-
mental transitions in glial lineage elaboration (Figures 4 and 5). We
found that the number of REST target genes shared between OL
lineage species increases during progressive maturation. The
transitions between OLpres R OLpros, OLpros R pmOLs, and
pmOLs R myOLs included cell types that shared 43, 78, and 256
target genes, respectively. For CoREST, we observed that the
transitions between OLpres R OLpros, OLpros R pmOLs, and
pmOLs R myOLs included cell types that shared 81, 63, and 464
target genes, respectively. In parallel with the findings for REST,
the final OL lineage transition (pmOLs R myOLs) included cell
types that shared the largest number of CoREST target genes.
The degree of overlap between profiles of REST and CoREST
targets during these OL developmental transitions, particularly the
final transition, suggests that highly complex and integrated
transcriptional regulatory mechanisms involving REST and
CoREST are required to orchestrate the expression of genes
involved in OL maturation and maintenance. These profiles imply
Figure 1. Expression and subcellular localization of REST and CoREST in glial developmental species. (A) Immunofluorescence
microscopy of REST and CoREST (TRITC) expression profiles in glial developmental cell types. REST and CoREST are expressed in the nucleus and
cytoplasm of all glial cell types, including astrocytes (AS), oligodendrocyte (OL) precursors (OLpre), OL progenitors (OLpro), post-mitotic OLs (pmOL),
and mature, myelin expressing OLs (myOLs). Antibodies to specific OL and AS developmental markers (FITC) were used to identify specific stages of
glial cell maturation. Scale bars=50 mm (OLpres-myOLs) and 10 mm (ASs), respectively. (B) Western blot analysis of REST and CoREST expression in
glial developmental species. REST and CoREST are ubiquitously expressed in all cell types examined in our developmental paradigm.
doi:10.1371/journal.pone.0007665.g001
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developmental stages, where they may either be dynamically
activated, repressed, or primed for subsequent actions. Further,
the numbers of shared targets during early developmental
transitions are significantly less than in the final transition
suggesting that regulation of largely distinct subsets of genes may
be important for earlier transitions while more common regula-
tory modules are responsible for terminal differentiation and
maturation.
We also identified specific genes targeted throughout all
developmental stages within the OL lineage (e.g, OLpres, OLpros,
pmOLs, and myOLs). We found five genes that are targeted by
REST, including genes encoding membrane proteins (Syt4 and
Gm691), a neuroendocrine secretory protein (Scg3), a G-protein
coupled receptor (Gpr158), and a solute carrier (Slc12A5). In
contrast, we found that CoREST did not target any genes during
all stages of OL lineage elaboration. Together, these findings
Figure 2. Profiles of REST and CoREST target genes in
macroglial developmental cell types. The number of exclusive
REST, exclusive CoREST, and REST and CoREST (REST-CoREST) target
genes uniquely present in individual glial cell types as identified
through chromatin immunoprecipitation on promoter chip (ChIP-chip)
experiments. We identified a total of 3,178 REST target genes and 4,060
CoREST target genes. Note the presence of a disproportionately high
number of CoREST target genes in OLpres. (B) The percentages of REST,
CoREST, or REST-CoREST target genes present in individual glial
developmental cell types that contain previously characterized
repressor element-1 (RE1) motifs [20,22].
doi:10.1371/journal.pone.0007665.g002
Figure 3. Comparative analysis of REST and CoREST target
gene profiles in glial and neuronal subtypes. The distinct and
overlapping profiles of REST, CoREST and REST-CoREST target genes
present throughout glial lineage elaboration and in neuronal subtypes
[cholinergic neurons (CHOLNs), medium spiny projection neurons
(MSNs), GABAergic neurons (GABANs), glutamatergic neurons
(GLUTNs)]. These observations are highly statistically significant with
corresponding p-values,0.0001 (i.e., cumulative probability calculated
using hypergeometric testing) for the number of overlapping glial and
neuronal genes in each comparison.
doi:10.1371/journal.pone.0007665.g003
Figure 4. Comparative profiles of REST target genes present
during seminal stages of oligodendrocyte lineage elaboration.
We examined the distinct and overlapping profiles of REST target genes
present in OL lineage species during progressive stages of OL lineage
maturation (OLpre R OLpro R pmOL R myOL).
doi:10.1371/journal.pone.0007665.g004
REST and CoREST in Glial Cells
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important for mediating seminal developmental processes
throughout progressive stages of OL lineage maturation.
Pathway Analysis of Composite Profiles of REST and
CoREST Target Genes
To compare the putative functional roles of REST and
CoREST, we analyzed composite profiles of REST and CoREST
target genes from all glial cell types using Ingenuity Pathways
Analysis (Table S2). Exclusive REST target genes and exclusive
CoREST target genes were selectively enriched for distinct
pathways highlighting potential differences in the roles played by
REST and CoREST in regulating developmental processes
important for glial lineage specification and maturation. Specifi-
cally, for exclusive REST target genes, these pathways included
TGF-b signaling, LPS-stimulated MAPK signaling, estrogen
receptor signaling, and VEGF signaling, whereas for exclusive
CoREST target genes these pathways included actin cytoskeleton
signaling, IGF-1 signaling, and PDGF signaling. Moreover, we
also identified commonly enriched pathways for exclusive REST
target genes and exclusive CoREST target genes, suggesting that
REST and CoREST modulate the same developmental processes
through different subsets of genes. These pathways included:
ephrin receptor signaling, integrin signaling, and axonal guidance
signaling. In addition, for REST-CoREST target genes, we
identified enriched pathways for Wnt/b-catenin signaling, gluta-
mate receptor signaling, and the ole of BRCA1 in DNA damage
response.
Pathway Analysis of REST and CoREST Target Genes in
Individual Glial Cell Types
To further examine the potentially distinct and overlapping
roles for REST and CoREST within individual glial cell types, we
examined REST and CoREST target genes in ASs and
throughout progressive stages of OL lineage maturation (Table
S3). For REST targets, we identified enriched pathways involved
in a diverse set of biological functions. For example, in ASs, these
pathways included the tyrosine metabolism pathway. In OLpres,
these pathways included the cytochrome P450 pathway. In
pmOLs, these pathways included glucocorticoid receptor signal-
ing, protein ubiquitination pathway, and EGF signaling. Finally, in
myOLs, these pathways included death receptor signaling,
apoptosis, Wnt/b-catenin signaling, GABA receptor signaling,
and estrogen receptor signaling.
Similarly, we found that CoREST targets are also involved in a
distinct and diverse array of biological pathways. In ASs, these
pathways included riboflavin metabolism. In OLpres, these
pathways included androgen and estrogen metabolism and the
complement system. In OLpros, these pathways included thyroid
hormone receptor/retinoid X receptor (TR/RXR) activation and
p53 signaling. In pmOLs, these pathways included axonal
guidance signaling and amyloid processing. Finally, in myOLs,
these pathways included Wnt/b-catenin signaling, death receptor
signaling, glutamate receptor signaling, neuregulin signaling,
synaptic long-term potentiation, and GABA receptor signaling.
REST and CoREST Target Genes Mediate Diverse
Developmental Processes in Glial Lineage Species
Astroglial functions. We identified unique REST and
CoREST target genes in ASs that modulate various functional
properties of ASs (Table S4). For example, we identified target
genes that encode enzymes involved in prostaglandin biosynthesis
and in modulating AS activation in response to brain injuries,
including Alox5 [26] and Ptgs2 [27,28]. In addition, we also found
target genes that are part of a recently described AS transcriptome
database [29] such as Wsb1, a SHH regulated E3 ubiquitin ligase,
which modulates cell proliferation, viability and stress responses
[30] and may be involved in mediating the increased proliferative
activity observed in activated ASs [31].
Oligodendrocyte specification and progressive matura-
tion. In each progressive stage of OL lineage maturation, we
uncovered a range of unique REST and CoREST target genes
encoding factors with roles in shaping early OL development as
well as in regulating the intrinsic OL developmental rheostat that
controls the fidelity of cell cycle exit and terminal differentiation
including myelinlation (Table S4) [32]. For example, in OLpres,
we found target genes encoding Cntn1/F3, an immunoglobulin
superfamily cell adhesion molecule critical for promoting OL
maturation [33,34,35]; Tcf4, a high mobility group (HMG) family
downstream effector of Wnt signaling and transcriptional inhibitor
of OL maturation and myelination genes [36,37,38,39]; and
Mobp, an essential myelin protein [40]. In OLpros, we identified
target genes encoding Sema3a, a guidance cue that directs OL
migration [41]; CD9, a tetraspanin family member expressed in
premyelinating OLs [42]; S100a10, an S100 family member
involved in cell cycle progression and OL differentiation [43]; and
LIFR, a cytokine receptor that promotes anti-apoptotic responses
in OLs and modulates cuprizone-induced demyelination and
myelin repair [44]. In pmOLs, we target genes that encode factors
including Gap43, a gap junction protein, and Sept5, a septin
cytoskelton protein, that are both involved in determining OL
morphology; Ccndbp1, Hoxa2, Olig2, and Sox4, which are all
responsible for transcriptional regulation of OL genes; and MBP,
which determines myelination status. In myOLs, we identified
genes that encode factors promoting OL differentiation and
myelin gene expression. Specifically, Zfp488 is an OL-specific
transcriptional co-regulator of Olig2 [45], and Myt1 is a
transcription factor that mediates the transition between
immature OL proliferation and terminal OL differentiation
Figure 5. Comparative profiles of CoREST target genes present
during seminal stages of oligodendrocyte lineage elaboration.
We examined the distinct and overlapping profiles of CoREST target
genes present in OL lineage species during progressive stages of OL
lineage maturation (OLpre R OLpro R pmOL R myOL).
doi:10.1371/journal.pone.0007665.g005
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target genes that are highly expressed in myOLs (e.g., Tmem10/
Opalin) [47,48], where they may promote OL terminal
differentiation and myelination.
In various combinations and permutations, REST and
CoREST also target genes encoding factors with key roles in
OL specification and progressive maturation, including basic helix
loop helix (bHLH) (e.g., Mash1/Ascl1, NeuroD4/Math3, and Id4),
high-mobility group (HMG) (e.g., Sox2, Sox8, and Sox11), and POU
domain (e.g., Pou3f2) transcription factors (Table S4). Mash1 acts
in a cell- and maturational stage-specific manner and is involved in
the elaboration of bipotent neuronal-oligodendrocyte progenitors
(N/OPs) and in promoting OL lineage specification, terminal
maturation, and myelin gene expression [49], while NeuroD4/
Math3 plays an even earlier role in neuronal versus glial fate
determination [50]. We identified other target genes encoding
factors with roles in OL lineage maturation [51], including Sox2,
important in OL cell cycle progression [52]; Sox11, expressed in
OLpres where it is thought to inhibit OL terminal differentiation
[53]; and Pou3f2, important for promoting Sox11 developmental
functions [54]. Interestingly, we also identified Sox8, another Sox
protein with dual roles in OL lineage progression and myelination.
Specifically, during early OL specification, Sox8 has an accessory
role in progressive OL maturation by cooperating with Sox9 [55].
In contrast, during later OL myelination, Sox8 cooperates with
Sox10 to induce the expression of myelin factors (e.g., MBP and
PLP) [55,56,57]. Moreover, we identified target genes encoding
other factors involved in progressive OL maturation, including:
Kcnj10, an inward-rectifying potassium channel required for OL
terminal differentiation and myelination [58]; Nog, a modulator of
TGF-b signaling essential for the development of ramified OLs
and myOLs [59]; Itgb1, an integrin required for mediating OL
axonal contact during myelination [60]; Mpzl1, a protein similar
to an integral peripheral myelin component [47,61]; NF1, a
membrane glycoprotein that modulates MBP gene transcription
[62]; ID4, a factor that differentially regulates myelination by
repressing MBP but inducing other myelin proteins, including PLP
and MAG [63]; and MBP, a myelin protein critical for OL
terminal differentiation and myelination [52,64].
Integrating our ChIP-chip data with gene expression data,
including our own (Table 1) and previous studies [47], extends and
further suggests that REST and CoREST may be critical for
promoting the timing and fidelity of OL lineage elaboration by
sequentially modulating of expression of immature and mature
OL lineage factors and regulating the expression of factors
essential for myelin gene programs. These findings may have
important implications for OL biology and for our understanding
of the pathogenesis of a spectrum of dysmyelinating and
demyelinating diseases as well as processes that may be
recapitulated during the process of remyelination following injury
or disease states [65,66]. These observations are also consistent
with the hypothesis that the REST complex may prime the local
chromatin environment for hierarchical developmental gene
expression similar to other epigenetic modifications [25].
Epigenetic regulation. Epigenetic regulation is now
emerging as an important cellular mechanism for mediating the
interplay between extrinsic and intrinsic signals, such as
morphogenic signaling pathways and transcription factor codes, to
determine cell type specific gene expression profiles [67,68]. In fact,
REST and CoREST recruit a diverse group of epigenetic factors to
their regulatory complexes where they play roles in cell type specific
transcriptional regulation and in cell fate determination [11,15].
Intriguingly, we found that REST and CoREST target a large
cohort of genes encoding epigenetic factors (Table S5) including
DNA methylation factors, such as DNA methyltransferases (e.g.,
Dnmt1) and methyl-CpG binding domain (MBD) proteins (e.g.,
Mbd2, Mbd3, and Mbd6); members of the SWI/SNF family of
chromatin remodeling enzymes (e.g., Smarcd2, Smarcc1, Smarcb1,
Smarcal1, Smarcad1, Smarca3, Smarca2, and Smarca1); histone
modifying enzymes, such as histone deacetylases (e.g., Hdac6 and
Hdac7a), histone demethylases (e.g., Jmjd1a, Kdm5c, and Utx)a n da
histone methyltransferase (e.g., Ehmt1); and adapter molecules
associated with the maintenance of higher-order chromosomal
organization, including chromosomal ATPase (e.g., Smc1a, Smc4,
and Smc6), high-mobility group (HMG)-box (e.g., Hmg20b and
Hmg20a), and non-histone chromodomain (e.g., Cbx1 and Cbx4)
proteins. These observations suggest that REST and CoREST
modulate transcription of this repertoire of epigenetic factors in a
glial subtype and developmental stage specific manner. Indeed,
recent studies show that epigenetic modulators, such as HDACs
(class I, II, and IV), are differentially expressed during OL lineage
elaboration[38,69,70]wheretheyplayimportant rolesinregulating
developmental stage specific stage gene expression. Furthermore,
many ofthese factors areassociated withREST, includingmembers
of the SWI/SNF factor family that serve as integral components of
REST and CoREST repressor complexes [11,15] and HMG-box
proteins that differentially modulate REST target gene expression
[71]. These findings suggest that REST and CoREST mediate the
elaboration of distinct glial chromatin environments at both
transcriptional and post-transcriptional levels.
Cell cycle regulation. REST and CoREST targeted genes
encoding various cell cycle regulators (Table S6). These include
Ccnd1, which modulates the G1/S phase transition [72] and
Table 1. Comparative analysis of REST and CoREST promoter
occupancy and corresponding gene expression profiles
during glial developmental transitions.
REST CoREST
AB +/2 +/2
NSC AS
No Yes 184/48 135/10
Yes No 23/94 90/270
N/OP OLpre
No Yes 130/32 299/167
Yes No 10/22 19/26
OLpre OLpro
No Yes 126/49 95/26
Yes No 30/13 166/39
OLpro pmOL
No Yes 41/127 73/169
Yes No 52/85 28/61
pmOL myOL
No Yes 197/83 109/54
Yes No 124/60 111/48
We examined REST and CoREST target gene expression profiles during the
specification of ASs (NSCsRASs) and OLpres (N/OPsROLpres) and during
progressive stages of OL lineage maturation (OLpresROLpros, OLprosR
pmOLs, and pmOLsRmyOLs). The absence or presence of REST and CoREST
promoter occupancy for target genes within each cell type are indicated by no
and yes. Each pair of numbers represents genes up regulated and down
regulated (+/2), respectively, during the transition from the proximal
progenitor (column A) to its immediate progeny (column B).
doi:10.1371/journal.pone.0007665.t001
REST and CoREST in Glial Cells
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Interestingly, Rb1 promotes cell cycle exit, in part, by
maintaining histone H3 lysine 27 (H3K27) trimethylation marks
on cell cycle genes [74]. These examples illustrate how REST and
CoREST chromatin-based regulatory mechanisms lead to glial
subtype specification and OL lineage maturation [74].
Association of Promoter Occupancy with Developmental
Gene Expression Profiles
To assess the potential roles of REST and CoREST in the
modulation of glial gene expression programs, we also correlated
changing profiles of REST and CoREST promoter occupancy
with differential target gene expression patterns in cell types
associated with critical developmental transitions. We examined
specification of ASs (NSCsRASs) and OLpres (N/OPsROLpres)
and progressive stages of OL lineage maturation (OLpresROL-
pros, OLprosR pmOLs, and pmOLsRmyOLs) (Table 1).
Specifically, we identified genes that displayed either gain or loss
of REST or CoREST promoter occupancy and also exhibited
differential expression between the two cell types comprising the
developmental transition. Among these, we found subsets of genes
with gain of REST or CoREST promoter occupancy during the
transitions that were associated with both gene activation and
repression. Conversely, we also identified subsets of genes with loss
of REST or CoREST promoter occupancy during the transitions
that were similarly associated with both gene activation and
repression. For example, among genes where REST was not
bound in pmOLs but bound in myOLs, 197 genes were up
regulated and 83 were down regulated in myOLs. Similarly,
among genes where CoREST was not bound in N/OPs but bound
in OLpres, 299 genes were up regulated and 167 genes were down
regulated in OLpres. In contrast, among genes where REST was
bound in NSCs but not bound in ASs, 90 genes were up regulated
and 270 genes were down regulated in ASs. Also, among genes
where CoREST was bound in OLpros but not bound in pmOLs,
41 genes were up regulated and 127 genes were down regulated in
pmOLs. These cumulative results suggest that differential
combinations of REST and CoREST promoter occupancy states
dynamically regulate the expression of a myriad of gene targets
with important roles in glial lineage elaboration, including both
positive (e.g., factors that regulate key glial transition states) and
negative (e.g., factors that mediate alternate neural and non-neural
lineages and processes) modulators of glial lineage maturation and
homeostasis.
Discussion
Although REST and CoREST are believed to orchestrate
neurogenesis by regulating the expression of neuronal differenti-
ation genes, our ChIP-chip studies suggest that these factors are
also important for modulating NSC-mediated glial lineage
specification and maturation. The developmental stage- and cell
type-specific profiles of target genes that we uncovered include
many factors known to promote AS and OL subtype specification
and progressive stages of OL lineage maturation including
myelination. We also identified target genes involved in a broad
array of cell-intrinsic processes, cell-cell communications, and
environmental signaling pathways that may similarly be involved
in determining aspects of glial cell identity and function. Indeed, it
is becoming increasingly clear that factors presumed to have more
general or homeostatic functions, such as those with roles in
endoplasmic reticulum (ER) stress, ubiquitin proteasome, and
autophagy pathways, may be implicated in glial developmental
biology and may be responsible for the pathogenesis of disorders
with selective glial cell vulnerability, such as Pelizaeus-Merzbacher
disease and Vanishing White Matter (VWM) disease [75]. In
addition, through corresponding gene expression analyses, we
observed that changes in REST and CoREST promoter
occupancy are associated with complex profiles of gene regulation,
including both activation and repression. These findings are
consistent with the emerging view that REST and CoREST
complexes act with high degrees of context-specificity depending
on developmental stage, cell type, and target gene locus.
Our results strongly suggest that, in addition to modulating
genes involved in neuronal differentiation, REST and CoREST
also selectively regulate genes encoding factors that promote the
acquisition of glial cell identity and function. For example, REST
and CoREST targeted genes are involved in key developmental
pathways that mediate AS specification, including Notch, JAK-
STAT, BMP, FGF, and EGF signaling, and OL specification and
progressive maturation, such as PDGF, SHH, MAPK, and FGF
signaling (Table S1) [76]. In addition, genes targeted by REST
and CoREST encode a number of transcription factors that, in
various combinations, govern almost every aspect of OL lineage
specification, proliferation, and terminal differentiation including
myelination. These include the HLH (e.g., E2A, HEB, Mash1,
Olig2, and Id4), Hox (e.g., Hoxa2), POU (e.g., Brn2), Sox (e.g., Sox4,
Sox8, and Sox11), Nkx (e.g., Nkx6.1), and zinc finger (e.g., Myt1 and
Zfp488) transcription factor families [77]. REST and CoREST
also targeted many genes that encode components of the myelin
sheath (e.g., Mal, Mobp, and Mpzl1).
Our results strongly suggest that REST and CoREST also
modulate the specific deployment of a very wide range of
epigenetic factors that may play important roles in sculpting glial
cell identity and function. These include genes encoding DNA
methylation factors (e.g., Dnmt1, Mbd2, Mbd3, and Mbd6); SWI/
SNF chromatin remodeling enzymes (e.g., Smarcd2, Smarcb1,
Smarcad1, and Smarca1); histone deacetylases (e.g., Hdac6 and
Hdac7a); histone demethylases (e.g., Utx and Smcx), including
Jumonji-enzymes (e.g., Jarid1c, Jarid1d, Jmjd1a, and Jmjd4); and
other adapter molecules associated with both euchromatic (e.g.,
Hmg20a) and heterochromatic (e.g., Cbx5 and Hmg20b) states that
may activate glial lineage specific genes and repress genes that are
expressed in alternate lineages. For example, methyl-CpG binding
domain proteins (MBDs) are generally thought to be expressed
only in neurons and to repress glial genes [78]. Intriguingly, we
found that REST targeted Mbd2 in OLpre, Mbd6 in pmOL, and
Mbd3 in myOL, while CoREST targeted Mbd6 in pmOL and
myOL and Mbd3 in myOL. These MBD genes contain RE1s, and
our observations further suggest that REST and CoREST
selectively modulate the expression of these genes during
progressive stages of OL lineage maturation. In addition, the cell-
and tissue-specific expression profiles and functions of various
HDAC enzymes are believed to be important for many different
aspects of neural lineage specification, maturation, and develop-
mental plasticity [79,80]. However, the mechanisms governing
HDAC expression are not well characterized. We found that
during OL lineage elaboration, REST and CoREST targeted
genes encoding HDACs from class II (e.g., Hdac6 and Hdac7) and
class III (e.g., Sirt1, Sirt2, and Sirt5). Together, these observations
suggest that REST and CoREST orchestrate a spectrum of
developmentally regulated and highly environmentally responsive
epigenetic processes that differentially control seminal glial fate
decisions.
Furthermore, our results strongly suggest that REST and
CoREST also regulate various aspects of the microtubule network
and cytoskeletal dynamics that are critical for OL maturation and
myelination. Interestingly, in the OL lineage, Sirt2 is co-expressed
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and has been implicated in the regulation of OL maturation and
myelination, in part, because it can act as a microtubule tubulin
deacetylase [81,82]. Sirt2 has also been noted to interact with
HDAC6, which can similarly act as a microtubule tubulin
deacetylase [81,82]. Unlike previous studies, we found that
HDAC6 is highly expressed in myOLs suggesting that it may
function in concert with Sirt2 and may be important for ensuring
the fidelity of OL lineage progression. In addition, REST and
CoREST targeted various genes encoding factors involved in
microtubule growth, stability, and function including members of
the tubulin (e.g., Tubb4, Tubb2a, Tuba2, Tubd1, and Tubg1), tubulin
chaperone (e.g., Tbca), tubulin tyrosine ligase-like (e.g., Ttll1 and
Ttll4), microtubule associated protein (e.g., Mapt), stathmin (e.g.,
Stmn1, Stmn2, Stmn3, and Stmn4), kinesin (e.g., Kif9, Kif6, Kif3c,
Kif2a, and Kif22), and dynein (e.g., Dync2li1, Dync2h1, Dync1li1,
Dync1i2, Dync1h1, and Dnaic1) families.
Moreover, our results also suggest that, in glial cells, REST and
CoREST modulate genes encoding various members of the
nuclear receptor superfamily (e.g., Nr5a1, Nr4a3, Nr3c1, Nr2f2,
Nr2e3, Nr2e1, Nr1h4, and Nr1d2), which act as dynamic sensors for
the extracellular and intracellular milieu and have crucial roles in
controlling neural development, homeostasis, and environmental
responses. Intriguingly, a recent study reported that a different
nuclear receptor, Nr4a2 (Nurr1), promotes a neuroprotective anti-
inflammatory response in both microglia and ASs through
CoREST-mediated transrepression of NF-kB activated pro-
inflammatory genes and further suggested that a similar
CoREST-mediated pathway may be widely used by other nuclear
receptors, particularly members of the Nr4a family [83]. While we
did not find that CoREST targets Nr4a2 in ASs, our observations
raise the interesting possibility that members of the nuclear
receptor superfamily may act through REST- and/or CoREST-
mediated transactivation and/or transrepression of target genes
while also being subject to context-specific transcriptional
regulation by REST and CoREST.
Indeed, this conclusion is supported by our observations that the
Nr2e1 (Tlx) gene is targeted by both REST and CoREST, along
with other studies showing that the Nr2e1 protein can interact
directly with the histone demethylase, LSD1, a member of the
CoREST complex, and recruit it to genomic Nr2e1 binding sites
where it remodels the local chromatin environment [84]. In
addition, further layers of complexity in REST-CoREST-nuclear
receptor regulation and function are suggested by the recent
finding that Nr2e1 participates in a dual negative transcriptional
feedback loop with the microRNA, miR-9 [85], which also has
similar transcriptional regulatory relationships with REST and
CoREST [16,86].
This example illustrates how REST and CoREST seem to be at
the nexus of the intricate circuitry embedded within epigenetic
networks, intracellular signaling pathways, metabolic processes,
and developmental programs responsible for encoding cell identity
and function within the nervous system. Our results further imply
that many families of genes not previously implicated in glial cell
biology are modulated by REST and CoREST in a developmental
stage- and cell type specific manner, which suggests that they may
have selective roles in promoting aspects of glial cell identity,
function, and connectivity and/or repressing characteristics of
alternate lineages. These include but are not limited to genes
encoding factors that define cell surface identity and connectivity
(e.g., olfactory receptors, vomeronasal receptors, and transmem-
brane proteins) and promote homeostasis (e.g., solute carriers,
DNA repair enzymes, and ER stress, cell cycle regulatory,
ubiquitin-proteasome, and apoptosis-associated factors) as well as
many additional families of proteins. Further characterization of
these context-specific REST and CoREST transcriptional sub-
modules and their regulatory topologies is necessary not only for
understanding the control of glial lineage elaboration but also for
defining the emergent properties of REST and CoREST networks
and their dynamic functions, including potential roles in disease
pathogenesis.
For example, REST inactivation, over expression, and copy
number variation are observed in various cancer phenotypes,
where they may promote loss of cellular identity and transforma-
tion through alterations in genomic stability, DNA methylation,
chromatin remodeling, and deregulation of oncogenes and tumor
suppressor genes. Indeed, REST, itself, is thought to have
paradoxical functions as both a tumor suppressor gene and an
oncogene, depending on the cellular context. Our results suggest
that, in glial cells, both REST and CoREST modulate genes in key
pathways responsible for the formation of glial tumors, such as
glioblastoma multiforme (GBM). These include but are not limited
to p53 (e.g., Mdm4 and Cdkn2a), retinoblastoma (e.g., Rb1), growth
factor (e.g., Pdgfrb, Fgfr1, Bambi, and Smad4), and receptor tyrosine
kinase phosphatidylinositol-3-OH kinase (RTK-PI3K) (e.g., Met,
NF1, and Akt1) signaling pathways. Because CoREST may
regulate these important pathways, exhibits close functional
relationships with REST, and has the capacity to recruit factors
known to modulate cellular transformation such as the transcrip-
tional corepressor, CtBP [87], and the oncogene, Znf217
[88,89,90], our data supports the conclusion that CoREST, like
REST, may also play a key role in cellular transformation in the
nervous system.
Furthermore, REST and CoREST also targeted genes
associated with oligodendrogliopathies. For example, we found
genes from genomic loci linked to multiple sclerosis (e.g., Abca8a,
Il2ra, Irf1, Prkca, Slc1a3, Tap2, and Ttyh2), the most common cause
of central nervous system demyelinating disease, and multisystem
atrophy (e.g., Tppp), a primarily glial disorder that is related to
Parkinson’s disease and characterized by deregulation in the
metabolism of myelin basic protein and tubulin polymerization
promoting protein [91]. These observations imply that, because of
their broad range of effects on DNA methylation, chromatin
remodeling, and gene modulation, REST and CoREST may be
key targets for epigenetic reprogramming not only in cancer but
also in many other glial diseases, particularly as epigenetic
remodeling is known to be important for modulating progressive
stages of OL lineage maturation [69,92,93,94].
In this study, we suggest that REST and CoREST each play
essential, distinctive and interrelated roles in promoting the
fidelity of glial cell identity, lineage maturation, maintenance of
homeostasis, and neural plasticity. REST and CoREST are
known to serve as nodes in highly integrated epigenetic
regulatory networks that include ncRNAs with multiple layers
of bidirectional feedback controls [16]. Therefore, our observa-
tions imply that these REST-CoREST-ncRNA epigenetic
networks and the genes that they influence may orchestrate the
developmental coupling of neurogenesis and gliogenesis, cellular
migration, and neural network integration and plasticity by
modulating AS functions, including regulation of microenviron-
mental niches and synaptic plasticity, as well as OL functions,
including mediation of neuronal-glial interactions and axonal
myelination. Furthermore, these complex developmental rela-
tionships may be critical for better characterizing a wide range of
central nervous system pathologies and for developing novel
diagnostic and therapeutic strategies that involve dynamic
epigenetic reprogramming of REST- and CoREST-mediated
neural fate decisions.
REST and CoREST in Glial Cells
PLoS ONE | www.plosone.org 8 November 2009 | Volume 4 | Issue 11 | e7665Materials and Methods
Cell Cultures
Culture preparations were generated as previously described
with minor modifications [49,95,96,97,98,99,100]. Briefly,
multilineage potential and more lineage restricted progenitor
species derived from embryonic day 14.5 (E14.5) ventral
forebrain regions of CD1 mice were plated and propagated in
serum free media (SFM) containing specified factors for various
time intervals, and subsequently examined by immunofluores-
cence microscopy to define developmental neural lineage profiles
[49,95,96,97,98,99,100], by Western blot analysis to detect
REST and CoREST protein expression [95,101], and by Qchip
and ChIP-chip to identify DNA binding sites for REST and
CoREST as previously described [102,103,104]. Primary neural
stem cell (NSC) clones were generated by application of basic
fibroblast growth factor (bFGF, 10 ng/ml) for 7 days in vitro
(DIV) and then dissociated using 0.05% trypsin (GIBCO) for 15
minutes at 37uC. Individual cells were re-propagated in bFGF for
an additional 2 DIV to form secondary NSC clones that were
used for experiments and are referred to herein as NSCs. The
expansion of secondary NSC clones was limited to 2 DIV to
avoid inclusion of differentiated neural species from this culture
condition. This culture paradigm eliminates intermediate neural
progenitor species and other proliferating neural developmental
cell types present in primary NSC clones and yields .98%
homogeneity. Thenumber of DIVrequiredfor theelaboration of
all differentiated progeny was determined to satisfy several
essential developmental and cellular criteria, including homoge-
neity of the developmental lineage species examined (.95%) and
the absence of alternative neural species. Lineage-restricted
neuronal-OL progenitor (N/OP) clones [49] were generated
from dissociated primary NSC clones by application of bFGF
and the N-terminal active form of Shh (N-Shh,100 ng/ml) for 2
DIV [98] to achieve .98% homogeneity. OL precursor cells
(OLpres) comprised .98% of the cell population that was
generated from N/OP clones by application of platelet-derived
growth factor (PDGF-AA, 10 ng/ml) after 2 DIV. Cellular
species representing progressive stages of OL lineage maturation
were generated by propagation in SFM containing laminin
(3 mg/ml, BD Biosciences) on poly-D-lysine (PDL) coated culture
dishes at non-confluent densities. OL progenitors (OLpros) were
generated from OL precursor species by application of PDGF-
AA (10 ng/ml) for an additional 2–4 DIV to achieve .95%
homogeneity. Cell culture composition and homogeneity re-
mained similar for the two subsequent developmental stages of
OL lineage maturation. Post-mitotic OLs (pmOLs) and mature,
myelin expressing OLs (myOLs) were generated from OL
progenitors by withdrawal of PDGF-AA for an additional 2
and 4 DIV, respectively [105]. Astrocytes (ASs), comprising
.98% purity, were generated by dissociation of secondary NSC
clones using 0.05% trypsin for 15 minutes at 37uCa n dr e -
propagation of individual cells in epidermal growth factor (EGF)
for 7 DIV with subsequent addition of bone morphogenetic
protein 2 (BMP2) for 5 DIV [99,100].
GABAergic neurons (GABANs) were generated by application of
BMP2 (10 ng/ml) to N/OPs propagated on poly-D-lysine (PDL)
coated culture dishes with the addition of laminin (3 mg/ml, BD
Biosciences) for 2 DIV [98]. Cholinergic neurons (CHOLNs) were
generated from E14.5 ventral forebrain-derived NSCs by minor
modification of a previously described method [106]. Individual cells
from primary NSC clones were plated in Neurobasal medium
(GIBCO) supplemented with N2 on PDL coated culture dishes with
the addition of laminin (3 mg/ml),bFGF(10 ng/ml),N-Shh(100 ng/
ml) and nerve growth factor (NGF, 200 ng/ml)for 2 DIV followed by
application of N-Shh and NGF for an additional 14 DIV. Medium
spiny projection neurons (MSNs) were generated from E14.5 ventral
forebrain derived NSCs by the modification of a previously defined
method [107]. Individual cells from primary NSC clones were plated
on PDL-coated cultures dishes containing Neurobasal, B27 and
laminin (3 mg/ml) and were treated with bFGF (10 ng/ml), N-Shh
(50 ng/ml) and brain derived neurotrophic factor (BDNF, 50 ng/ml)
for 1 DIV followed by application of BDNF (100 ng/ml) for another
14 DIV. Glutamatergic neurons (GLUTNs) were generated directly
from radial glial cells (RG) that were obtained from dorsal forebrain
derived primaryNSC clones.Briefly, individual cellsdissociated from
dorsal forebrain derived NSC clones were propagated in SFM on
PDL-coated dishes in SFM supplemented with laminin (3 mg/ml) in
t h ep r e s e n c eo fb F G F( 1 0n g / m l )a n dL I F( 1 0n g / m l )f o r2D I Vt o
elaborate RG of .97% homogeneity. GLUTN were subsequently
generated by withdrawalofbFGFand LIF from RGfor an additional
4 DIV. To ensure that all neuronal subtypes species reached .99%
homogeneity before being utilized in ChIP experiments, we added
10 mm cytosine arabinoside (Sigma) to the culture media 24 hours
before harvesting the cells and thereby eliminated all dividing cells by
apoptosis [108,109,110]. We followed institutional IACUC guide-
lines for experiments in which primary mouse tissue specimens were
utilized.
Cell Line Cultures
The mouse oligodendrocyte precursor cell line, Oli Neu [111]
was a kind gift of Dr. J. Trotter (University of Mainz, Germany).
Cells were grown on PDL-coated culture dishes. Immature Oli-
neu cells were maintained in growth medium consisting of
DMEM supplemented with 2 mM L-glutamine, 1 mM sodium
pyruvate, 10 ng/ml biotin, 100 mg/ml apotransferrin, 100 mM
putrescine, 20 nM progesterone, 30 nM sodium selenite, 5 mg/
ml insulin and 1% horse serum. The induction of oligodendrocyte
differentiation was promoted by switching cells to media
containing 1 mM dibutryl-cAMP (Sigma) as previously described
[111]. Oli-neu cells were continuously maintained at 37uCi n5 %
CO2 at a humid atmosphere.
Immunofluorescence Microscopic Analysis
Immunofluorescence microscopic analysis was performed as we
have previously described [95,96].
Specific Antibody Preparations
All antibodies exhibited selective immunoreactivity for mouse
cells and tissue sections, and each antibody exhibited a complete
absence of alternate cross-reactivity. The following antibodies
were utilized: CoREST, REST, and normal rabbit IgG (1:100,
Upstate, Temecula, CA, USA), the neuroepithelial marker (nestin,
mIgG1, 1:200, Pharmingen), N/OP markers (Olig2, goat IgG,
1:300, R&D and Mash1, mIgG1, 1:100, Pharmingen), OLpre
marker (NG2, rIg, 1:500, Chemicon), the OLpro marker (O4,
mIgM, 1:700, Sigma), the pmOL markers (GC/O1, mIgM, 1:350,
Chemicon), the myOL marker (MBP, mIgG2b, 1:500 Sternberger
Monoclonals) and the AS marker (GFAP, mIgG1, 1:400, Sigma).
Isotype specific secondary antibodies were utilized at a 1:1500
dilution according to the required fluorophore combinations
(Invitrogen). Secondary antibodies utilized for Western blot
analysis were HRP conjugated (GE Healthcare).
Western Blot Analysis
Cell cultures were processed for Western blot analysis as
described previously [95,101,112,113]. Briefly, cells were homog-
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50 mm Tris-HCl, pH 8.0, EDTA-free protease inhibitors cocktail
(Roche) and 0.5 mm phenylmethylsulfonyl fluoride using a glass–
Teflon homogenizer (10 strokes at 800 rpm) on ice, centrifuged at
900 g for 10 min and lysed in sodium dodecyl sulfate sample-
loading buffer for Western blot analysis.
Growth Factor Preparations
To generate the various neural stem, progenitor and more
differentiated glial species the following growth factor preparations
were utilized: recombinant bFGF (Collaborative Biomedical
Products), recombinant EGF, N-Shh and PDGF-AA (R&D
Systems) and BMP2 (gift from Genetics Institute). To generate
the comparative neuronal subtype species the following additional
growth factor preparations were utilized: recombinant mouse b-
NGF (R&D Systems), human BDNF (BioVision), recombinant
BMP2 (gift from Genetics Institute) and recombinant LIF
(Chemicon).
Quantitative Chromatin Immunoprecipitation (QChIP)
Cultures were prepared essentially as previously described
[49,98] and used in chromatin immunoprecipitation (ChIP)
[102,103,104], with minor modifications. Between 1610
6 and
3610
6 cells were used per antibody. The following antibodies were
utilized: CoREST, REST, and normal rabbit IgG (Upstate,
Temecula, CA, USA). An additional control included the absence
of antibody (input chromatin). Antibodies were first validated
using a peptide competition assay. For 1610
6 cells, 10 mgo f
antibody was used. Enrichment of fragments by ChIP was
quantified by using 1 ml of ChIP product for real-time PCR using
the SYBRH Green kit (Applied Biosystems, Foster City, CA, USA)
in a 7000 Real Time PCR systemH (Applied Biosystems, CA,
USA). Validated CoREST and REST promoter binding sites were
used as positive controls, while a non-target gene promoter was
used as a negative control. DCT values were obtained using the
DDCT method [114]. For validation of ChIP-chip results, primers,
50 to 150 base pairs in length, were designed to flank the binding
peak within each of the respective promoter sequences.
ChIP-Chip Assays
To investigate the specific roles of CoREST and REST
throughout early neural developmental stages, we examined the
differential binding profiles of CoREST and REST by determin-
ing their gene-specific targets through a series of ChIP-chip
experiments. Chromatin immunoprecipitation is an in vivo
technique that can be used to identify transcription factor binding
sites. To determine whether the CoREST and REST antibodies
were specific for known targets, ChIP was first performed in an
Oli-Neu cell line [111] with a CoREST antibody, REST antibody,
control IgG, or no antibody (input). Samples were then analyzed
by quantitative PCR (QPCR) using primers specific for both a
known and previously validated CoREST and REST target gene,
GluR2, and a negative control [4,115]. Chromatin immunopre-
cipitation targets were determined by utilizing a fold-enrichment
greater than 1.5. We then performed a series of ChIP-chip
experiments in order to build a comprehensive profile of CoREST
and REST target genes throughout early neural developmental
stages. The mouse promoter array was based on MM8/mouse
genome Build 36 from February 2006 (NimbleGen Systems,
Madison, WI). The design is based only on normal RefSeq genes
(17,355 genes) and includes 2,000 base pairs upstream of the
transcriptional start sites and 500 base pairs downstream. The
probe size ranges from 50-75 base pairs and the spacing interval is
100 base pairs.
ChIP-Chip Data Analysis
Analysis was performed essentially as previously described
[116]. Enrichment was calculated for each probe by computing
the log-ratio value for the ChIP immunoprecipitation product in
comparison to the input chromatin. For all ChIP-chip exper-
iments, in order to find promoter peaks, a maximum log-ratio
value for a window consisting of three consecutive probes was
determined for both experimental data and a random permutation
of the data. A positive threshold was then established to determine
the probability for real enrichment. This positive threshold was
determined by examining signals of known CoREST and REST
binding sites, GluR2, and calbindin, respectively [4,115]. A 90%
positive threshold was used. The gene target lists were generated
based on the intersection of genes across a minimum of two arrays
for each experimental paradigm. We validated these ChIP-chip
results with QchIP in a representative sample of cell types from
our developmental paradigm and found 83% and 94% correlation
for CoREST and REST, respectively. These results indicate that
the ChIP-chip technique and data analysis methods used to
characterize CoREST and REST target genes are effective
approaches for identifying valid binding sites.
Functional Classification of Target Genes
Target genes were functionally annotated by the use of
Ingenuity Pathways Analysis (IngenuityH Systems, www.ingenuity.
com).
Gene Expression Assays and Analysis
The gene expression array was based on MM8/mouse genome
build 36 from February 2006 (NimbleGen, Madison, WI). The
Robust Multi-Array Average (RMA) algorithm was used and data
was also analyzed by the significant analysis of microarray
methods (SAM). Each of the different cell types was compared
to neural stem cells. Three biological replicates were conducted for
each cell type.
Supporting Information
Table S1 Composite profiles of REST and CoREST target
genes in glial developmental cell types. For the ChIP-chip data, the
value 1 denotes gene promoter occupancy. For the gene
expression data, the value represents the expression in the cell
type relative to expression in neural stem cells. The Robust Multi-
Array Average (RMA) algorithm and significant analysis of
microarray methods (SAM) were used to analyze the expression
data. Three biological replicates were conducted for each cell type.
Found at: doi:10.1371/journal.pone.0007665.s001 (2.14 MB
XLS)
Table S2 Comparative analysis of pathways enriched in
composite profiles of REST, CoREST, and REST-CoREST
target genes. The values in each row represent the degree of
pathway enrichment (2LogP) for each set of target genes. Only
pathways exhibiting high degrees of statistical significance
(2LogP.2) are included. Target genes were analyzed using
Ingenuity Pathways Analysis (IngenuityH Systems, www.ingenuity.
com).
Found at: doi:10.1371/journal.pone.0007665.s002 (0.03 MB
XLS)
Table S3 Comparative analysis of pathways enriched in REST
and CoREST target genes for individual glial developmental cell
types. The values in each row represent the degree of pathway
enrichment (2LogP) for each set of target genes. Only pathways
exhibiting statistical significance (2LogP.1.3) are included.
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(IngenuityH Systems, www.ingenuity.com).
Found at: doi:10.1371/journal.pone.0007665.s003 (0.03 MB
XLS)
Table S4 Selective profiles of REST and CoREST target genes
encoding factors with known roles in glial developmental cell
types.
Found at: doi:10.1371/journal.pone.0007665.s004 (0.76 MB
XLS)
Table S5 Selective profiles of REST and CoREST target genes
encoding epigenetic factors in glial developmental cell types.
Found at: doi:10.1371/journal.pone.0007665.s005 (0.12 MB
DOC)
Table S6 Selective profiles of REST and CoREST target genes
encoding cell cycle regulators in glial developmental cell types.
Found at: doi:10.1371/journal.pone.0007665.s006 (0.18 MB
DOC)
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